112635 ⎘
Measuring or testing processes involving enzymes, nucleic acids or microorganisms ; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage; Specific hybridization probes for papilloma
Electrochemical Genosensor Based on Target-Triggered DNAzyme Activity
#2CELLULARITY CONTROL FOR NUCLEIC ACID ASSAYS
#3DYNAMIC APPLICATION OF AN EXCLUSIVE MULTICLASS CLASSIFIER FOR EVALUATION OF VIRAL ASSOCIATED CANCERS
#4ULTRA SENSITIVE PROBES FOR DETECTING BIOMARKERS
#5SALIVA-BASED DETECTION OF ORAL CANCER
#6METHODS AND DEVICES FOR DETECTION OF ORTHOGONAL CLASSES OF DISEASE BIOMARKERS
#7METHODS, SYSTEMS, AND COMPOSITIONS FOR DETECTION OF NUCLEIC ACIDS
#8A METHOD, USES, SYSTEM AND KIT FOR DETECTING A HUMAN PAPILLOMAVIRUS GENOTYPE ASSOCIATED WITH DEVELOPMENT OF CERVICAL, ORAL OR ANOGENITAL CANCER IN A SUBJECT AND FOR DETERMINING THE GENOTYPE OR GENOTYPES THEREOF
#9MULTIPLEXED PATHOGEN DETECTION USING NANOPLASMONIC SENSOR FOR HUMAN PAPILLOMAVIRUS
#10SYSTEMS AND METHODS FOR DETECTION OF MICROBIAL NUCLEIC ACIDS
#11PROBE DESIGN FOR DETECTION OF ONCOGENIC VIRUSES
#12METHODS AND USES OF CRISPR CASCADE REACTIONS FOR CRISPR DIAGNOSTICS
#13Peptides and combinations of peptides for use in immunotherapy against oropharyngeal squamous cell carcinoma (OPSCC) and other cancers
#14METHOD FOR DETECTING THREE TARGET NUCLEIC ACIDS IN SAMPLE
#15METHODS OF TREATMENT FOR HPV MALIGNANCIES
#16METHOD FOR PRODUCING ELECTROCHEMILUMINESCENCE NANOPROBE, ELECTROCHEMILUMINESCENCE NANOPROBE, ELECTROCHEMILUMINESCENCE SENSOR, ELECTROCHEMILUMINESCENCE DETECTION METHOD, AND KIT FOR ELECTROCHEMILUMINESCENCE DETECTION
#17SCREENING SYSTEMS AND METHODS FOR HPV-ASSOCIATED CERVICAL DISEASE
#18Viral Neoepitopes and Uses Thereof
#19MATERIALS AND METHODS FOR MEASURING HPV CTDNA
#20METHODS AND SYSTEMS FOR HPV DETECTION AND QUANTIFICATION
#21ASSAY FOR DETECTING CLOSELY-RELATED SEROTYPES OF HUMAN PAPILLOMAVIRUS (HPV)
#22ASSAYS FOR MEASURING NUCLEIC ACIDS
#23Multiplexed nucleic acid detection kit for human papilloma virus (HPV) typing, and detection method
#24METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
#25METHOD FOR QUANTIFYING DNA FRAGMENTS IN A SAMPLE BY SIZE
#26HPV Detection from urine analyte in male, non-binary and transgender patients
#27METHODS FOR DETECTING AND PREDICTING GRADE 3 CERVICAL EPITHELIAL NEOPLASIA (CIN3) AND/OR CANCER
#28SWITCHABLE NUCLEIC ACID-SCAFFOLDED CATALYTIC SYSTEMS AND METHOD OF USE
#29Methods Of Treatment Of High Grade Squamous Intraepithelial Lesion (HSIL)
#30HPV E6, E7 MRNA Assay and Methods of Use Thereof
#31DNA POLYMERASE, APTAMER, WARM-START DNA POLYMERASE AND PREPARATION METHODS AND APPLICATION THEREOF
#32VIRAL AND HOST BIOMARKERS FOR DETECTION, THERAPEUTIC EFFECTIVENESS, AND MONITORING OF CANCER LINKED TO SARS-CoV-2 AND HUMAN PAPILLOMA VIRUS
#33BEAD COMPLEX FOR DETECTION OF NUCLEIC ACID MOLECULES IN BIOLOGICAL SAMPLES AND METHOD OF DETECTING NUCLEIC ACID USING THE SAME
#34Methods for molecularly characterizing cervical cell samples
#35METHODS FOR DIAGNOSIS AND IN VITRO RISK STRATIFICATION FOR HEAD AND NECK CANCER BASED ON EXOSOMAL MRNAS
#36DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#37COMPOSITIONS AND METHODS FOR THE SELECTIVE DETECTION OF TUMOR-DERIVED VIRAL DNA
#38TREATMENT OF HPV-RELATED DISEASES
#39Biomarkers for head and neck cancer and methods of their use
#40Pooled Crispr Inverse PCR Sequencing (PCIP-Seq): Simultaneous Sequencing of Viral Insertion Points and the Integrated Viral Genomes with Long Reads
#41DETECTION AND SEQUENCING OF FRAGMENTED DNA
#42METHOD AND KIT FOR DETECTING HUMAN PAPILLOMAVIRUSES
#43PRIMER SETS FOR THE DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 (HPV16) AND HUMAN PAPILLOMAVIRUS TYPE 18 (HPV18), THE METHOD OF DETECTING HPV16 AND HPV18 INFECTIONS, THE USE OF A PRIMER SET FOR THE DETECTION OF HPV16 AND HPV18 INFECTIONS
#44DETECTION OF CIRCULATING TUMOR DNA USING DOUBLE STRANDED HYBRID CAPTURE
#45METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS
#46MATERIALS AND METHODS FOR DETECTING HUMAN PAPILLOMA VIRUS
#47METHODS AND COMPOSITIONS FOR TARGETED SINGLE-STRANDED CLEAVAGE AND TARGETED INTEGRATION
#48ANTIBODY-DNA CONJUGATES AND HPV DETECTION AND TREATMENT
#49ASSOCIATION BETWEEN INTEGRATION OF HIGH-RISK HPV GENOMES DETECTED BY MOLECULAR COMBING AND THE SEVERITY AND/OR CLINICAL OUTCOME OF CERVICAL LESIONS
#50Compositions and methods for the selective detection of tumor-derived viral DNA
#51COMPOSITION OF PRIMERS FOR DETECTING HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION
#52PAPER-BASED, NUCLEIC ACID-DETECTING KIT AND METHOD FOR ANALYSIS OF PCR AMPLICON
#53Biomarkers for Cervical Cancer
#54A METHOD FOR DETERMINING THE SEVERITY OR GRADE OF HUMAN PAPILLOMAVIRUS (HPV)-INDUCED DYSPLASIA
#55Methods of identifying patients as having an increased likelihood of having a human papillomavirus (HPV)-associated cancer or recurrence of an Hpv-associated cancer
#56METHODS AND COMPOSITIONS FOR DETECTION OF HPV DNA AND DIAGNOSIS AND MONITORING OF HPV-ASSOCIATED CANCERS
#57Human papilloma virus as predictor of cancer prognosis
#58COMPOSITIONS AND METHODS FOR DETECTING HUMAN PAPILLOMAVIRUS
#59ASSOCIATION BETWEEN INTEGRATION OF VIRAL AS HPV OR HIV GENOMES AND THE SEVERITY AND/OR CLINICAL OUTCOME OF DISORDERS AS HPV ASSOCIATED CERVICAL LESIONS OR AIDS PATHOLOGY
#60DETECTION AND CLASSIFICATION OF HUMAN PAPILLOMAVIRUS ASSOCIATED CANCERS
#61MARKERS FOR PRE-CANCER AND CANCER CELLS AND THE METHOD TO INTERFERE WITH CELL PROLIFERATION THEREIN
#62COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEM
#63KIT AND METHOD FOR COLLECTING BODY FLUID FOR MEDICAL DIAGNOSIS
#64METHOD FOR DETECTING TARGET NUCLEIC ACID SEQUENCE USING CLEAVED COMPLEMENTARY TAG FRAGMENT AND A COMPOSITION THEREFOR
#65P16 positive tumor stratification assays and methods
#66Detection of nucleic acids from multiple types of human papillomavirus
#67Method for detecting nucleic acid based on prokaryotic argonaute protein and application thereof
#68Functionalized DNA Dendrimers For Gene Delivery To Cells
#69Portable diffraction-based imaging and diagnostic systems and methods
#70MONOAZO DYES WITH CYCLIC AMINE AS FLUORESCENCE QUENCHERS
#71Assay for detecting closely-related serotypes of human papillomavirus (HPV)
#72Methods for molecularly characterizing cervical cell samples
#73Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
#74Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages
#75Detection of nucleic acids from multiple types of human papillomavirus
#76COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND DETECTION OF TUMORS AND CANCER PROGNOSIS
#77Methods and compositions for human papillomaviruses and sexually transmitted infections detection, identification and quantification
#78Human papilloma virus as predictor of cancer prognosis
#79Methods and compositions for targeted single-stranded cleavage and targeted integration
#80Biomarkers for head and neck cancer and methods of their use
#81ASSOCIATION BETWEEN INTEGRATION OF HIGH-RISK HPV GENOMES DETECTED BY MOLECULAR COMBING AND THE SEVERITY AND/OR CLINICAL OUTCOME OF CERVICAL LESIONS
#82METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
#83Detection of nucleic acids from multiple types of human papillomavirus
#84MOLECULAR FINGERPRINTING METHODS TO DETECT AND GENOTYPE DNA TARGETS THROUGH POLYMERASE CHAIN REACTION
#85Method for quantifying DNA fragments in a sample by size
#86HPV detection method
#87Detection of nucleic acids from multiple types of human papillomavirus
#88Detection of nucleic acids from multiple types of human papillomavirus
#89Kit for detecting silent sexually transmitted diseases (SSTDS) in a urine sample
#90Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples
#91Compositions and methods for detecting human papillomavirus nucleic acid
#92DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#93Viral neoepitopes and uses thereof
#94Methods and compositions for direct chemical lysis
#95Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#96Method for detecting target nucleic acid sequence using cleaved complementary tag fragment and a composition therefor
#97HPV SCREENING PLATFORM
#98Portable diffraction-based imaging and diagnostic systems and methods
#99ASSOCIATION BETWEEN INTEGRATION OF HIGH-RISK HPV GENOMES DETECTED BY MOLECULAR COMBING AND THE SEVERITY AND/OR CLINICAL OUTCOME OF CERVICAL LESIONS
#100METHOD OF UTILIZING ENZYME FOR ISOTHERMAL NUCLEIC ACID HYBRIDIZATION
#101Method and system for characterization for female reproductive system-related conditions associated with microorganisms
#102Monoazo dyes with cyclic amine as fluorescence quenchers
#103OPTIMIZED REAL-TIME NUCLEIC ACID DETECTION PROCESSES
#104Methods and compositions for targeted single-stranded cleavage and targeted integration
#105Separation of human papillomavirus nucleic acids from biological samples
#106Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#107HUMAN PAPILLOMA VIRUS AS PREDICTOR OF CANCER PROGNOSIS
#108USE OF VLP FOR THE DETECTION OF NUCLEIC ACIDS
#109NUCLEIC ACID SEQUENCES FOR TYPING DETECTION OF CUTANEOUS HUMAN PAPILLOMAVIRUSES AND USE THEREOF
#110METHOD FOR DIAGNOSING, QUANTIFYING, TREATING, MONITORING OR EVALUATING CONDITIONS, DISEASES OR DISORDERS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS (HPV) INFECTION
#111HPV E6, E7 MRNA Assay and Methods of Use Thereof
#112Compositions and methods for detecting human papillomavirus nucleic acid
#113Monoazo dyes with cyclic amine as fluorescence quencers
#114Methods for molecularly characterizing cervical cell samples
#115Magnetic nanostructure for detecting and isolating cell-free DNA comprising cationic polymer and magnetic-nanoparticle-containing conductive polymer
#116ASSAY
#117Assay system to identify HPV replication inhibitors in HT-screen
#118Next-Generation Sequencing-Based Genotyping Assay for Human Papilloma Virus (HPV)
#119Assay for detecting closely-related serotypes of human papillomavirus (HPV)
#120Diagnostic transcript and splice patterns of HR-HPV in different cervical lesions
#121DROSOPHILA MODEL OF HUMAN CERVICAL CANCER
#122Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
#123Detection of nucleic acids from multiple types of human papillomavirus
#124Monoazo dyes with cyclic amine as fluorescence quenchers
#125Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#126Method for detecting and typing high-risk human papillomaviruses
#127Biomarkers for head and neck cancer and methods of their use
#128Biomarkers for cervical cancer
#129Methods and compositions for targeted single-stranded cleavage and targeted integration
#130COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEM
#131USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER
#132Methods and Systems for Predicting Whether a Subject Has a Cervical Intraepithelial Neoplasia (CIN) Lesion from a Suspension Sample of Cervical Cells
#133Broad range gene and genotype papillomavirus transcriptome as a biomarker of papillomavirus-associated cancer stages
#134HPV E6, E7 MRNA Assay and Methods of Use Thereof
#135Method of treating cancer using immune checkpoint inhibitor
#136SCREENING TEST FOR DETECTING THE PRESENCE OF ONCOGENIC HPV VIRUSES
#137Nucleic acid detection method and kit
#138METHOD FOR DETECTION OF HUMAN PAPILLOMAVIRUS
#139Method and system for diagnostic testing
#140Cervical cancer diagnosing method and diagnostic kit for same
#141Methods of treating head and neck cancer
#142METHOD FOR DIAGNOSING, QUANTIFYING, TREATING, MONITORING OR EVALUATING CONDITIONS, DISEASES OR DISORDERS ASSOCIATED WITH HUMAN PAPILLOMA VIRUS (HPV) INFECTION
#143ASSAY DEVICES AND ASSAY ASSEMBLIES
#144MOLECULAR DETECTION OF RNA
#145Markers for pre-cancer and cancer cells and the method to interfere with cell proliferation therein
#146Ultra Sensitive and Specific Multiplex Biosensor System Based on Multiple Cooperative Interactions
#147Monoazo dyes with cyclic amine as fluorescence quenchers
#148Optimized real time nucleic acid detection processes
#149Kit and method for collecting body fluid for medical diagnosis
#150Self-contained biological assay apparatus, methods, and applications
#151METHOD AND COMPOSITION FOR DETECTION OF ONCOGENIC HPV
#152Portable diffraction-based imaging and diagnostic systems and methods
#153Method for prediction of prognosis by human papillomavirus DNA integration pattern
#154Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#155Methods and compositions for direct chemical lysis
#156COMPREHENSIVE AND COMPARATIVE FLOW CYTOMETRY-BASED METHODS FOR IDENTIFYING THE STATE OF A BIOLOGICAL SYSTEM
#157Fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in human papilloma virus E6 protein
#158METHOD FOR SPECIES IDENTIFICATION BY USING MOLECULAR WEIGHTS OF NUCLEIC ACID CLEAVAGE FRAGMENTS
#159A METHOD OF CERVICAL SCREENING
#160Quantitative multiplexed identification of nucleic acid targets
#161DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#162Dual sequence-capture method for quantifying trans renal HPV DNA in urine
#163HPV Detection in Urine
#164Primers and probes for detecting human papillomavirus and human beta globin sequences in test samples
#165Method And System For Detection Of An Organism
#166Genotyping method
#167Compositions and methods for detecting human papillomavirus nucleic acid
#168Self-contained biological assay apparatus, methods, and applications
#169USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER
#170Detection of nucleic acids from multiple types of human papillomavirus
#171Detection of nucleic acids from multiple types of human papillomavirus
#172PRDM14 and FAM19A4, molecular diagnostic markers for HPV-induced invasive cancers and their high-grade precursor lesions
#173Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells
#174METHOD OF DETERMINING THE PRESENCE OR ABSENCE OF A TARGET NUCLEIC ACID IN A CELL SAMPLE
#175FLUORESCENT NANOPARTICLE COMPOSITES THEMSELVES, PROCESS FOR THE PREPARATION OF SUCH COMPOSITES, AND USE IN RAPID DIAGNOSIS SYSTEMS WITH AFFINITY TO BIOLOGICAL MOLECULES
#176In situ detection of early stages and late stages HPV infection
#177Self-contained biological assay apparatus, methods, and applications
#178Methods and compositions for assessing copy number of target polynecleotides
#179Magnetic nanocomposite retrieval of nucleotide sequence
#180Compositions and reaction mixtures for the detection of nucleic acids from multiple types of human papillomavirus
#181Correlation of disease activity with clonal expansions of human papillomavirus 16-specific CD8+ T-cells in patients with severe erosive oral lichen planus
#182Hybridization assay detection probes for detecting human papilloma virus in a sample
#183Methods for detecting human papillomavirus-associated cancers
#184Human papilloma virus as predictor of cancer prognosis
#185Method of determining HPV integration site in genome of human tissue sample, system and use thereof
#186Method for detection of high risk human papillomavirus
#187DIFFERENTIATION BETWEEN TRANSIENT AND PERSISTENT HIGH-RISK HPV INFECTION BY IN SITU HYBRIDIZATION
#188Method for using permuted nucleic acid probes
#189Compositions and reaction mixtures for the detection of nucleic acids from multiple types of human papillomavirus
#190Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#191Assay for detecting closely-related serotypes of human papillomavirus (HPV)
#192Encoded polymeric microparticles
#193PROCESSES AND COMPOSITIONS FOR DETECTING HUMAN PAPILLOMA VIRUS TYPES
#194COMPOSITIONS AND METHODS FOR RECOVERY OF NUCLEIC ACIDS OR PROTEINS FROM TISSUE SAMPLES FIXED IN CYTOLOGY MEDIA
#195BIOMARKERS FOR THE DETECTION OF HEAD AND NECK TUMORS
#196HPV E6, E7 MRNA assay and methods of use thereof
#197Integrated Assay that Combines Flow-Cytometry and Multiplexed HPV Genotype Identification
#198Control nucleic acids for multiple parameters
#199Self-contained biological assay apparatus, methods, and applications
#200METHOD OF EVALUATING ORAL CANCER RISK IN HUMAN
#201Self-contained biological assay apparatus, methods, and applications
#202HPV DETECTION AND QUANTIFICATION BY REAL-TIME MULTIPLEX AMPLIFICATION
#203Compositions, reaction mixtures and methods for detecting nucleic acids from multiple types of human papillomavirus
#204Human papilloma virus as predictor of cancer prognosis
#205Compositions, reaction mixtures and methods for detecting nucleic acids from type A1 and/or type C1 human papillomavirus
#206Compositions, reaction mixtures and methods for detecting nucleic acids from multiple types of human papillomavirus
#207DETECTION OF INFECTION BY A MICROORGANISM USING SMALL RNA SEQUENCING SUBTRACTION AND ASSEMBLY
#208METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA
#209COMPOSITIONS AND METHODS RELATING TO MOUSE PAPILLOMA VIRUS
#210COMPOSITIONS AND METHODS RELATING TO MOUSE PAPILLOMA VIRUS
#211Nucleic Acids For Multiplex Organism Detection and Methods Of Use And Making The Same
#212Rapid genotyping analysis and devices thereof
#213DETECTION OF NUCLEIC ACIDS BY TYPE-SPECIFIC HYBRID CAPTURE METHODS
#214OLIGONUCLEOTIDE SETS FOR DETECTION OF HUMAN PAPILLOMAVIRUS
#215Detection of nucleic acids by target-specific hybrid capture method
#216MULTIPARAMETER ASSAY
#217OLIGONUCLEOTIDE AMPLIFICATION PRIMERS FOR TARGETING ONCOGENIC HPV
#218DNA Chip for Genotyping of Human Papilloma Virus, Kit Having Same, and Method for Genotyping
#219COMPOSITIONS AND METHODS FOR DETECTING VIRAL INFECTION USING DIRECT-LABEL FLUORESCENCE IN SITU HYBRIDIZATION
#220INTEGRATED ASSAY THAT COMBINES FLOW-CYTOMETRY AND MULTIPLEXED HPV GENOTYPE IDENTIFICATION
#221Method and Kit for Identifying Compounds Capable of Inhibiting Human Papilloma Virus Replication
#222Detection of HPV
#223Set of probes for the detection and typing of 46 human papillomavirus mucosal types
#224High power laser system
#225HPV DNA Methylation Patterns of Diagnostic or Prognostic Significance in Cervical Cancer Screening
#226Method for detecting human papilloma virus based on Solexa sequencing method
#227PROBES FOR GENOTYPING LOW-RISK-HPV
#228Compositions, reaction mixtures and methods for detecting nucleic acids from type A1 and/or type C1 human papillomavirus
#229PROBE FOR HPV GENOTYPE DIAGNOSIS AND ANALYSIS METHOD THEREOF
#230MEANS AND METHODS FOR PREDICTING THE RISK OF MORTALITY OF PATIENTS WITH HPV POSITIVE OROPHARYNGEAL SQUAMOUS CELL CANCER
#231Fast results hybrid capture assay and system
#232Materials and methods for detection of HPV nucleic acids
#233DETECTION OF EARLY STAGES AND LATE STAGES HPV INFECTION
#234GENOTYPING METHOD
#235Human papilloma virus probes for the diagnosis of cancer
#236Optimized real time nucleic acid detection processes
#237Fluorescent nanoparticle composites themselves, process for the preparation of such composites, and use in rapid diagnosis systems with affinity to biological molecules
#238Gene Expression Biomarkers in PAP Test Material for Assessing HPV Presence and Persistence
#239Methods for detecting human papilloma virus-associated cancers
#240KIT AND METHOD FOR SEQUENCING A TARGET DNA IN A MIXED POPULATION
#241RNASCOPE® HPV ASSAY FOR DETERMINING HPV STATUS IN HEAD AND NECK CANCERS AND CERVICAL LESIONS
#242Methods for detecting human papilloma virus-associated cancers
#243Control nucleic acids for multiple parameters
#244MATERIALS AND METHODS FOR GENOTYPING AND QUANTIFYING A HIGH-RISK HUMAN PAPILLOMAVIRUS
#245CHROMATOGRAPHIC SYSTEM FOR NUCLEIC ACID DETECTION
#246Quantitative multiplexed identification of nucleic acid targets
#247DIAGNOSTIC MARKERS FOR DETERMINING THE PREDISPOSITION TO THE DEVELOPMENT OF CERVICAL CANCER AND OLIGONUCLEOTIDES USED FOR THE DETERMINATION
#248Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (CIN) lesion from a suspension sample of cervical cells
#249GENOTYPING OF BOVINE PAPILLOMAVIRUS GENOTYPES
#250Method for detection of human papillomavirus (HPV) type
#251Method for discrimination of metaplasias from neoplastic or preneoplastic lesions
#252Diagnostic transcript and splice patterns of HPV16 in different cervical lesions
#253High-risk human papillomavirus detection
#254High-risk human papillomavirus detection
#255High-risk human papillomavirus detection
#256Fast results hybrid capture assay and associated strategically truncated probes
#257Genetic marker for detection of human papillomavirus
#258Detection of nucleic acids from multiple types of human papillomaviruses
#259Biomarkers for human papilloma virus-associated cancers
#260HPV TYPES AND VARIANTS ASSOCIATED WITH CERVICAL CANCER AND THE USES THEREOF
#261Method of determining and confirming the presence of an HPV in a sample
#262DIAGNOSIS OF VIRAL INFECTIONS BY DETECTION OF GENOMIC AND INFECTIOUS VIRAL DNA BY MOLECULAR COMBING
#263"TEST AND TREAT" STRATEGY FOR TREATING TRANSFORMING HPV INFECTION
#264Method of detecting tumor-associated DNA in plasma or serum with a premalignant solid tumor
#265Diagnostic transcript and splice patterns of HR-HPV in different cervical lesions
#266Self-contained biological assay apparatus, methods, and applications
#267Method of Detection of Nucleic Acids With a Specific Sequence Composition
#268Application of surface plasmon resonance technology for detecting and genotyping HPV
#269Biomarkers for the detection of head and neck tumors
#270Oligonucleotides for detecting human papilloma virus in a test sample
#271Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids
#272Method of detecting tumor-associated hypermethylated DNA in plasma or serum
#273Assay for detecting closely-related serotypes of human papillomavirus (HPV)
#274Method for Determining Presence or Absence of Abnormal Cell
#275Method of Detection of Nucleic Acids with a Specific Sequence Composition
#276METHOD OF EVALUATING ORAL CANCER RISK IN HUMAN
#277Human papilloma virus (HPV) detection using nucleic acid probes, microbeads and fluorescent-activated cell sorter (FACS)
#278RAPID GENOTYPING ANALYSIS FOR HUMAN PAPILLOMAVIRUS AND THE DEVICE THEREOF
#279ASSESSMENT OF HUMAN PAPILLOMA VIRUS-RELATED DISEASE
#280Method to identify and predict disease progression of human papilloma virus-infected lesions
#281VITRO DIAGNOSTIC KIT FOR IDENTIFICATION OF HUMAN PAPILLOMAVIRUS IN CLINICAL SAMPLES
#282Compositions and methods for recovery of nucleic acids or proteins from tissue samples fixed in cytology media
#283Detection of nucleic acids by target-specific hybrid capture method
#284Methods and compositions for direct chemical lysis
#285METHODS AND KITS FOR DETERMINING VIRAL LOAD IN CLINICAL SAMPLES
#286Method of detecting tumor-associated DNA in plasma or serum from humans without cancer
#287Composition comprising an oligonucleotide mixture for improved detection of human papillomavirus genotypes
#288Method for detecting cancer cell caused by HPV, method for determining whether or not tissue is at stage of high-grade dysplasia or more severe stage, and primer set and kit used therefor
#289Detection of nucleic acids by type-specific hybrid capture method
#290Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical Cancer
#291DETECTION OF HUMAN PAPILLOMAVIRUS
#292DIAGNOSING AND PROTECTING HORSES AGAINST PAPILLOMAVIRUS
#293Detection method for cervical HPVS
#294GOLD NANOPARTICLE HPV GENOTYPING SYSTEM AND ASSAY
#295PRIMER, PROBE, DNA CHIP CONTAINING THE SAME AND METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS AND DETECTION KIT THEREOF
#296PRIMERS AND PROBES FOR DETECTION OF HIGH RISK GROUP GENO-TYPE HUMAN PAPILLOMAVIRUS DNA, A QUALITATIVE ASSAY METHOD OF THE SAME DNA USING THEM AND A QUALITATIVE ASSAY KIT OF THE SAME DNA
#297Diagnostic Methods for Diseases Caused by a HPV Infection Comprising Determining the Methylation Status of the HPV Genome
#298Oligonucleotide amplification primers for targeting oncogenic HPV
#299Assays for measuring nucleic acids
#300Primer set and probe for detection of human papillomavirus